XLO

NASDAQStock

Xilio Therapeutics, Inc.

$0.50-0.01 (-2.19%)

52-Week Range

$0.51

$1.15

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

-0.02

Volume

350.8K

Avg Volume

440.9K

Performance

-14.24%

-21.34%

-31.98%

YTD

-23.88%

-36.10%

-81.47%

-96.80%

Price Chart

ETF Exposure

XLO is held by 7 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	35	$28	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,271	$1K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	6	$4	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	723,745	$431K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	3,806	$3K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	328	$264	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	367,825	$219K	$84.10B	0.05%

About XLO ETF Exposure

Xilio Therapeutics, Inc. (XLO) is held by 7 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $0.50. Investors can gain exposure to XLO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold XLO, sorted by portfolio weight.